Adult Vaccine Market is projected to reach US$ 22 Billion by the year
2024.

Nearly all countries across the globe have introduced a well-organized
National immunization Programs in their vaccination schedule to overcome
the outbreak of vaccine-preventable diseases. Several organizations such
as Global Immunization Vision and Strategy (GIVS), WHO's Global Vaccine
Action Plan, The GAVI Alliance are putting their best to reduce the
occurrence of vaccine-preventable diseases around the world which
certainly is driving the adult vaccine market sturdily.

Rising prevalence of diseases, growing awareness among the people
regarding vaccine-preventable diseases, increasing investments by
companies to develop new vaccines and increasing governments and other
healthcare authorities (Bill & Melinda Gates Foundation) funding for
promoting immunization programs as well as for the developments &
distribution of the vaccines are some other key factors which are
anticipated to augment the growth of global adult vaccine during the
forecast period.

Key Highlights

Pneumococcal Vaccine is likely to grow at a noteworthy rate over the
coming years